Abstract

There is a paucity of data on cardiovascular outcomes in patients with end-stage renal disease (ESRD) after implantation of an implantable cardiac defibrillator (ICD) or cardiac resynchronization therapy (CRT). We enrolled 7,825 Kaiser Permanente members across 6 geographical regions of the United

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call